Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8958 |
High Similarity |
NPD3748 |
Approved |
0.8658 |
High Similarity |
NPD3750 |
Approved |
0.8516 |
High Similarity |
NPD6599 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8471 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8431 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8408 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8389 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8366 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8344 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8313 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8303 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8228 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8205 |
Intermediate Similarity |
NPD920 |
Approved |
0.8182 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD919 |
Approved |
0.8105 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8077 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7975 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7964 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7962 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7939 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7919 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7853 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7826 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7823 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7823 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7821 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7821 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7806 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7742 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7736 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7736 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7727 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7707 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7683 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7683 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7677 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7667 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3972 |
Approved |
0.759 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7584 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7578 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7566 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7546 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7542 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7471 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7469 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7466 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7453 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7452 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7429 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7419 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7415 |
Intermediate Similarity |
NPD17 |
Approved |
0.741 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7405 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD2353 |
Approved |
0.74 |
Intermediate Similarity |
NPD3225 |
Approved |
0.74 |
Intermediate Similarity |
NPD1876 |
Approved |
0.74 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7399 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7386 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7384 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7346 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7342 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7342 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7342 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7342 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7338 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7315 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7308 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2344 |
Approved |
0.729 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7288 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD2897 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7238 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7233 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7222 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7191 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7168 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7168 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7152 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7119 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7119 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7112 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7093 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7056 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7033 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7006 |
Intermediate Similarity |
NPD411 |
Approved |
0.7 |
Intermediate Similarity |
NPD37 |
Approved |
0.6994 |
Remote Similarity |
NPD2654 |
Approved |
0.6984 |
Remote Similarity |
NPD6781 |
Approved |
0.6984 |
Remote Similarity |
NPD6777 |
Approved |
0.6984 |
Remote Similarity |
NPD6776 |
Approved |
0.6984 |
Remote Similarity |
NPD6782 |
Approved |
0.6984 |
Remote Similarity |
NPD6780 |
Approved |
0.6984 |
Remote Similarity |
NPD6779 |
Approved |
0.6984 |
Remote Similarity |
NPD6778 |
Approved |
0.6978 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD4966 |
Approved |
0.6977 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD4965 |
Approved |
0.6974 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6959
|
Remote Similarity |
NPD8151 |
Discontinued |